title: Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus.
authors.forename: P
authors.initials: P
authors.lastname: Tarján
authors.forename: S
authors.initials: S
authors.lastname: Sipka
authors.forename: G
authors.initials: G
authors.lastname: Lakos
authors.forename: E
authors.initials: E
authors.lastname: Kiss
authors.forename: G
authors.initials: G
authors.lastname: Ujj
authors.forename: G
authors.initials: G
authors.lastname: Szegedi
mesh_terms: D000328:Adult; D000368:Aged; D017152:Antibodies, Antiphospholipid / Q000097:blood / Q000187:drug effects*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000494:pharmacology*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008875:Middle Aged
chemical_list: D017152:Antibodies, Antiphospholipid; D007252:Influenza Vaccines